I dont think they are accepting in public that they
stuffed it up bug time .
They are trying to change course.
Hard to say exactly when Nuva and E4 comes,
Same re new generics that are v close to approval and big numbers. 'They have gone cold on that Vs earlier remarks.
They can still pull out some thing.
Dmage has been done.
Market has written it off now for some time and that is all priced in i think.
Question remains when the 2 big ones come and start kicking some goals.
Waiting mode.
Ann: 2019 AGM CEO's Speech, page-148
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
